Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07169877 · ClinicalTrials.gov registry record
Does a Minimally Invasive Approach to Liver Resection Improve Postoperative Outcomes?
A clinical trial of Hepatic Neoplasms, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 9,411
- Enrollment target
- 1
- Study location
NCT07169877 is a study of Hepatic Neoplasms that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 9,411 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07169877, a study of Hepatic Neoplasms, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 9,411 participants
- Enrollment target
- 1
- Study location
Study Summary
A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify adult patients who underwent liver resection between 2022 and 2023. Primary outcomes included 30-day mortality, sepsis, septic shock, readmission, and reoperation.
Conditions Studied
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,411 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07169877
The ClinicalTrials.gov registry entry for NCT07169877 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9,411 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hepatic Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT07169877 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07169877 about?
NCT07169877 is a clinical study titled "Does a Minimally Invasive Approach to Liver Resection Improve Postoperative Outcomes?". A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify adult patients who underwent liver resection between 2022 and 2023. Primary outcomes included 30-day mortality, sepsis, septic shock, readmissi...
What is the current status of trial NCT07169877?
This trial is currently completed. The enrollment target is 9,411 participants. The study started on 2022-01-01. Estimated completion is 2023-12-31.
What conditions does trial NCT07169877 study?
This clinical trial studies the following conditions: Hepatic Neoplasms.
Who is sponsoring clinical trial NCT07169877?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07169877 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.